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Background: Penicillium marneffei disseminates hematogenously and can infect most organs, though infection
leading to osteolysis is extremely rare. We describe the clinical and laboratory features, management, and outcomes
of patients with penicilliosis marneffei (PSM) with osteolytic lesions.
Methods: This retrospective study was conducted between January 1, 2003 and May 1, 2014 at the First Affiliated
Hospital of Guangxi Medical University. Patients who presented with culture and/or histopathologic proof of
disseminated PSM within osteolytic lesions were included.
Results: P. marneffei infection was diagnosed in 100 patients (65 HIV-infected and 35 HIV-negative). Fourteen patients,
all HIV-negative, (14/35, 40%) had osteolytic lesions. The most common comorbidity was diabetes mellitus, though
previous glucocorticoid therapy, β-thalassemia, breast cancer, and Langerhans cell histiocytosis also occurred. Five
patients had no comorbidity. Fever, malaise, ostealgia, weight loss, and anemia were the most common symptoms,
followed by cutaneous lesions, lymphadenopathy, hepatosplenomegaly, cough, sputum, and stethalgia. Ostealgia,
joint pain, and joint disorders were also recorded. White blood cell and neutrophil counts were increased (mean
22.3 ± 7.4 × 109 cells/L; mean 18.84 ± 4.5 × 109 cells/L, respectively). The most common sites were the vertebrae, skull
and femur, ribs and ilium, though the clavicle, scapula, humerus, and tibia were also involved. Radiography and
computed tomography (CT) showed multiple radiolucencies with moth-eaten bone destruction, periosteal proliferation,
bone fracture, and surrounding soft-tissue swelling. Emission CT showed significantly increased uptake in many skeletal
regions. Positron emission tomography/CT showed generalized lymphadenopathy, bone metabolic activity, and bone
destruction. The 18 F-FDG standard uptake value was increased in the entire skeleton (mean 6.16). Twelve patients
received antifungal therapy, four of whom died during treatment, and eight recovered, though four of these
eight relapsed within 3–24 months. Two patients discontinued treatment because of severe multiple organ failure
and died.
Conclusions: Osteolysis is often overlooked in HIV-negative individuals with disseminated P. marneffei infection.
However, P. marneffei involving the bone and leading to osteolysis may indicate severe systemic disturbance, and
is characterized by a poor prognosis, high recurrence rate, and the need for prolonged antifungal treatment.
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Table 1 Clinical manifestations in patients infected with





Weight loss 13 92.85
Anaemia 13 92.85
Ostealgia 13 92.85
Cutaneous lesions 12 85.71
Lymphadenopathy 11 78.57
Hepatosplenomegaly 10 71.43
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Penicilliosis marneffei (PSM) is a deep fungal infection
caused by Penicillium marneffei, and one of the most
common opportunistic infections among patients with
AIDS in Southeast Asia [1]. PSM is categorized as either
localized or disseminated. Disseminated PSM usually
affects the monocyte-macrophage system in multiple or-
gans including the skin, lungs, and the reticuloendothe-
lial system [2], while P. marneffei infection of the bone
leading to osteolytic lesions is extremely rare [3]. In this
study, we retrospectively analyzed the medical records
and clinical characteristics of 14 patients diagnosed with
disseminated PSM with osteolytic lesions between January
1, 2003 and May 1, 2014, at the First Affiliated Hospital of
Guangxi Medical University. We describe the clinical and
laboratory features, management, and outcomes of these
patients to provide evidence for the correct diagnosis and
early treatment of this condition.
Methods
Medical records
The medical records of 100 patients diagnosed with
PSM between January 1, 2003 and May 1, 2014, at the
First Affiliated Hospital of Guangxi Medical University
were reviewed. Among these, 14 patients with osteolytic
lesions were retrospectively evaluated. Patient informa-
tion, including demographics (sex, age, and occupation),
medical history (present history, comorbidities, and previ-
ous therapy), auxiliary examination results (hematological
tests, serological tests, immune status, imaging examina-
tions, and pathological and microbiological tests), and
treatment, was collected from medical records and sum-
marized for analysis.
This study was approved by the First Affiliated
Hospital of Guangxi Medical University Signation Ethical
Committee. All patients provided written informed
consent.
Diagnostic criteria for disseminated PSM
P. marneffei was isolated from clinical specimens includ-
ing blood, bone marrow, bone, sputum, lung, or dis-
charge from skin lesions and cultured on Sabouraud
dextrose agar (SDA) at 25°C and 37°C. Positive P. mar-
neffei cultures were characterized by dimorphic fungi
that grew as a mold at 25°C and as a yeast at 37°C [4].
P. marneffei was identified based on cytology and histo-
pathology from tissues and secretions stained with peri-
odic acid-Schiff stain or Wright–Giemsa stain, by light
microscopy. The yeast form of P. marneffei has a charac-
teristic morphology including a transverse septum [5].
Diagnostic criteria for PSM with osteolytic lesion
Patients were diagnosed according to the following cri-
teria: (i) P. marneffei identified in bone and/or bonemarrow biopsy samples using histopathology, cytologic
smears, and fungal culture; (ii) disseminated PSM with
osteolytic lesions diagnosed based on the presence of
osteolytic lesions on imaging examination, clinical symp-
toms including ostealgia, improvement after receiving
antifungal treatment alone, and exclusion of other
diseases that cause osteolysis (tuberculosis, cancer,
hematological diseases, and other fungal infections
such as African histoplasmosis, blastomycosis, cryptococ-
cosis, and coccidioidomycosis).
Results
Demographic data and clinical characteristics
During the 11-year study period, 100 patients were diag-
nosed with disseminated PSM according to the inclusion
criteria, including 65 HIV-infected and 35 HIV-negative
patients. Of these, only 14 patients, all HIV-negative,
had osteolytic lesions and were enrolled. The incidence
of P. marneffei with osteolytic lesions in HIV-negative
patients was therefore 40% (14/35). The study popula-
tion included nine men and five women with a median
age of 42.17 years (range 22–67 years). Their occupa-
tions included farmer (n = 8), laborer (n = 3), cadre (n = 2),
and student (n = 1). HIV-negativity was determined as
negative for interferon-γ autoantibody using repeated
enzyme-linked immunosorbent assay (ELISA) testing. Co-
morbidities included diabetes mellitus (n = 4), previous
glucocorticoid therapy (n = 2), β-thalassemia (n = 1), breast
cancer (n = 1), Langerhans cell histiocytosis (n = 1), and no
comorbidities (n = 5). Fever, malaise, ostealgia, weight loss,
and anemia were the most frequent symptoms, followed
by cutaneous lesions, lymphadenopathy, hepatosplenome-
galy, cough, sputum, and stethalgia. Ostealgia, joint pain,
and joint disorders were also present (Table 1).
Table 2 Skeletal localization in patients infected with
Penicillium marneffei with osteolysis (n = 14)
Types of bones and site Patients
No. %
Skull 6 42.85
Bones of the trunk Vertebrae 10 71.43
Ribs 5 35.71
Sternum 2 14.28














Bones of foot 1 7.14
Sacrum 1 7.14
Cartilage 1 7.14
Joint involvement 5 35.71
Soft tissue swelling 7 50
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Complete blood count examinations revealed increased
white blood cell levels in 12 patients (85.71%) (mean
22.3 ± 7.4 × 109 cells/L, range 13.3–35 × 109 cells/L). The
hemoglobin concentration was decreased in 13 patients
(92.85%) (mean 81.71 ± 3.2 g/L, range 65–116 g/L). Neu-
trophils were increased in 13 patients (92.85%) (mean
18.84 ± 4.5 × 109 cells/L, range 8.8–28.2 × 109 cells/L).
The CD4 and CD8 lymphocyte counts were determined
in 12 patients by flow cytometry and were decreased in
nine patients (75%). Serum biochemical analysis revealed
a mean serum albumin concentration of 20.1 ± 3.2 g/L
below the normal range in 13 patients (92.85%, range
11.0–31.4 g/L). Six patients (42.85%) showed kidney dys-
function. C-reactive protein concentration and erythro-
cyte sedimentation rate were increased in all patients.
Chest radiography and computed tomography
Chest computed tomography (CT) indicated pulmonary
consolidation in three patients (21.43%), cavities in five
(35.7%), disseminated inflammation in 12 (85.71%), and
interstitial disease involving the pleura in two (14.28%).
Ten (71.43%) patients had mediastinal and/or/ hilar
lymphadenopathy, and nine (64.28%) had pleural inflam-
matory reaction and/or pleural effusion. Four (28.57%)
patients had pericardial effusion, and three (21.43%) had
seroperitoneum.
Skeletal localization
In the 14 patients, P. marneffei infection involved mul-
tiple bony structures as follows: bones of the trunk (n = 11,
78.57%), limbs (n = 10, 71.43%), skull (n = 6, 42.85%), and
cartilage (n = 1, 7.14%). The most common sites were the
vertebrae (n = 10, 71.43%), skull and femur (n = 6, 42.85%),
and ribs (n = 5, 35.71%). The ilium was affected in four
(28.57%) patients, the clavicle, scapula, humerus, and tibia
in three (21.42%), the radius, sternum, innominatum, fib-
ula, and bones of the hand in two (14.28%), and the elbow
joint, ischium, pubis acetabulum, bones of the foot, and
the sacrum were implicated in one (7.14%) patient. Five
(35.71%) patients showed joint involvement. Soft-tissue in-
flammation was identified surrounding the bone in seven
(50%) patients (Table 2).
Imaging examinations
Radiographic and CT examinations showed multiple ra-
diolucencies, resembling a moth-eaten pattern of bone
destruction (Figure 1) in eight cases (57.14%). Periosteal
proliferation (Figure 2A) was identified in two cases
(14.28%), fracture (Figure 2A and B) in six cases (42.85%),
and surrounding soft-tissue swelling (Figure 1C) in five
cases (35.71%). Emission CT (ECT) was performed in five
cases and showed significantly increased uptake in mul-
tiple bones (Figure 3). Positron emission tomography/CT(PET/CT) was performed in two cases and showed diffuse
lymphadenopathy, whole-body bone metabolic activity,
and destruction in multiple bones. The 18 F-FDG standard
uptake value (SUV) was increased in the entire skeleton
(mean 6.16, range 2.5–9.6).
Fungal culture and histopathology
Fluid was aspirated from the bone marrow, blood, pleural
effusion, seroperitoneum, subcutaneous abscess, skin ulcer,
and dermal secretions, inoculated onto SDA, and incu-
bated at 37°C and 25°C. Twelve cases were confirmed
by positive P. marneffei culture. P. marneffei was isolated
from sputum samples (1/14, 7.14%), venous blood (3/14,
21.42%), bone marrow (2/14, 14.28%), bronchoalveolar lav-
age fluid (1/14, 7.14%), pus from a subcutaneous abscess
(3/14, 21.42%) and dermal lesion secretions (3/14, 21.42%).
In addition, seven cases were diagnosed with P. marneffei
infection by histopathology or cytology of specimens ob-
tained from pulmonary (1/14, 7.14%), lymph node (2/14,
14.28%), bone marrow (2/14, 14.28%, Figure 4A), bone
(1/14, 7.14%, Figure 4B), and skin lesions (2/14, 14.28%).
Figure 1 Radiography and computed tomography showing osteolytic lesions characterized by multiple lucent defects with a moth-eaten
destruction of bone in the head of the radius (A), ulna (A), rib (B), sternum (C), vertebrae (D), and ilium (D), and swelling in surrounding soft
tissues (B, C).
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Twelve patients received intravenous amphotericin B
deoxycholate (0.6–1.0 mg/kg/day) followed by oral itra-
conazole (400 mg/day). There was no consistent dur-
ation of antifungal therapy. Twelve patients received
antifungal therapy, four of whom died during treatment.
The other eight patients recovered, four of whom
showed no recurrence, but the other four experienced a
relapse 3–24 months later during follow-up. One of
these patients received intravenous amphotericin B deoxy-
cholate followed by itraconazole antifungal treatment forFigure 2 Radiography and computed tomography showing periostea
pathologic fracture (B) in the humerus.18 months, but relapsed 6 months after discontinuing
treatment. Antifungal treatment was discontinued in two
patients because of severe multiple organ failure, and these
patients subsequently died.
Discussion
Penicilliosis is a common but serious opportunistic fun-
gal infection in AIDS patients in Southeast Asia, but is
also increasingly observed in HIV-negative individuals.
PSM disseminates hematogenously to other locations,
with the reticuloendothelial system, skin, and lungsl proliferation in the innominatum and femur (A), and a
Figure 3 Emission computed tomography (CT) showing increased radioactive concentration in the brustwirbels, sternum, ilium, and
left clavicle (A). Positron emission tomography/CT showed generalized lymphadenopathy, increased whole-body bone metabolic activity, and
generalized skeletal destruction. The 18 F-FDG standard uptake value was increased in the whole skeleton and was 5.1 in the sternum (B), and 6.1
in the femur and clavicle (C).
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ever, P. marneffei infection of the bone leading to
osteolytic lesions is extremely rare [3].
In the current retrospective analysis, 100 patients were
diagnosed with disseminated PSM, including 65 HIV-
infected and 35 HIV-negative patients. All of the 14 pa-
tients with osteolytic lesions were HIV-negative, indicatingFigure 4 Histopathology of cervical vertebral (periodic acid-Schiff sta
yeast-like or sausage-like cells measuring 2–3 μm in diameter with a transv
1000×) (B).a high incidence rate of PSM with osteolytic lesions of 40%
in HIV-negative patients. The presence of P. marneffei
infection with osteolytic lesions predominantly in HIV-
negative patients was consistent with previous reports
[7,8]. Thus, despite the importance of osteolytic lesions,
they are easily overlooked in HIV-negative patients with
P. marneffei infection.in, 400×) (A) and bone marrow samples. Numerous intracellular
erse septum were observed (arrows, periodic acid-Schiff staining,
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patients with P. marneffei infection because of their
significantly higher white cell population and stron-
ger neutrophil function compared with HIV-positive
patients [6,7]. HIV-positive patients also have rela-
tively higher serum antigen titers, while HIV-negative
patients have higher serum antibody concentrations, as
determined by P. marneffei-specific mannoprotein Mp1p
ELISA [6]. In HIV-negative patients, when P. marneffei
disseminates to an osseous site, the significant focal
neutrophil aggregation results in localized granulomas
and abscesses, leading to significantly increased uptake
at osteolytic sites on bone ECT and increased whole-
body bone metabolic activity on PET/CT. In contrast,
neutrophil function is decreased in immunodeficient
HIV-positive patients, and P. marneffei infection of os-
seous sites is therefore rare. There is a prevailing hy-
pothesis that osteolytic lesions typically occur at sites
of neutrophil accumulation, where the release of pro-
teolytic enzymes leads to tissue lysis, liquefaction, and
necrosis [3].
In our study, PSM with osteolytic lesions could in-
volve any bone, including bones of the trunk, limbs,
skull, and tracheal cartilage. The most commonly in-
volved sites were the vertebrae, skull, femur, and ribs,
followed by the ilium, clavicle, scapula, humerus, and
tibia. The radius, sternum, innominatum, fibula, bones
of the hand, humerus, ischium, pubis acetabulum, bones
of the foot, sacrum, and cartilage were also involved.
Most patients also presented with swelling and tender-
ness in the soft tissues and joints surrounding the bones.
The most striking findings were multiple well-delineated
osteolytic lesions, which indicated a predilection for
flat bones and long bones, consistent with previous
studies [7,8].
The radiographic findings revealed well-circumscribed
osteolytic lesions with multiple lucent defects show-
ing a moth-eaten appearance, periosteal proliferation,
and fracture. ECT showed significantly increased up-
take in many parts of the skeleton, while PET/CT
showed increased whole-body bone metabolic activity
and diffuse skeletal destruction. 18 F-FDG SUV was in-
creased in the entire skeleton, with a mean 18 F-FDG
SUV of 6.16. Collectively, these findings resemble those
of malignancy. Diagnosis is often delayed because peni-
cilliosis marneffei is considered a rare condition in
HIV-negative individuals. The radiographic findings
usually lag behind the clinical findings by weeks or
months, and the variable radiographic presentations
and lesion distributions resemble those seen in osteo-
myelitis caused by tuberculosis, nontuberculous myco-
bacterial infection, tumors, and other fungal conditions
such as African histoplasmosis, blastomycosis, crypto-
coccosis, and coccidioidomycosis [9-11]. In our studypopulation, osteolytic lesions were a common but easily
overlooked finding in HIV-negative individuals with
P. marneffei infection. P. marneffei infection should
therefore be considered as one of the common causa-
tive organisms in the differential diagnoses of fungal
osteomyelitis.
Taking clinical symptoms and signs into consideration,
P. marneffei osteomyelitis can be diagnosed by its radio-
logical features, typical clinical features, histopatho-
logic examination, and organism culture, specifically
from bone, bone marrow, and skin lesions. Bone biopsy
with image guidance can increase the positivity rate of fun-
gal cultures.
Penicilliosis is very susceptible to antifungal treatment,
and P. marneffei is susceptible to itraconazole and
amphotericin B in vitro [12]. The recommended dos-
age and duration of treatment among HIV-infected
patients are intravenous amphotericin B deoxycholate
0.6–1.0 mg/kg/day for 2 weeks, followed by oral itra-
conazole 400 mg/day for 8–10 weeks [13]; however,
there is currently no recommended treatment for HIV-
negative individuals. Six patients died in the current
study, representing a high mortality (42.85%), while a fur-
ther four patients relapsed 3–24 months later despite
long-term antifungal treatment, representing a high re-
currence rate (28.57%). The patients in this study re-
ceived antifungal treatment for a longer duration than
individuals without osteolysis. There are currently no
standard recommendations for the appropriate treatment
duration and for prophylaxis of PSM with osteolysis,
and treatment depends on the severity of the infection,
the response to therapy, and the patient’s immune sta-
tus [1]. Surgery and external fixation should be per-
formed in patients with persistent or refractory bone
disease, such as pathologic fracture and pyogenic osteo-
myelitis. Our anecdotal experience revealed that relapse
was more common in patients who received a shorter
duration of treatment. P. marneffei involving the bone
and leading to osteolysis thus demonstrates the poten-
tial of systemic infection to cause severe lesions, and to
be associated with poor prognosis and a high recur-
rence rate, highlighting the need for prolonged antifun-
gal treatment.
Conclusions
PSM disseminates hematogenously to other locations.
However, P. marneffei infection of the bone leading to
osteolytic lesions is extremely rare. Osteolysis is often
overlooked in HIV-negative individuals with dissemi-
nated P. marneffei infection. However, P. marneffei in-
volving the bone and leading to osteolysis may indicate
severe systemic disturbance, and is characterized by a
poor prognosis, high recurrence rate, and the need for
prolonged antifungal treatment.
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